Evaluation of safety, tolerability and efficacy of Temsirolimus in patients with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice

被引：0
|
作者：
Krekeler, G. [1 ]
Neuhof, A. [1 ]
Dreyling, M. [2 ]
Hess, G. [3 ]
Kalanovic, D. [1 ]
机构：
[1] Pfizer Pharma GmbH, Berlin, Germany
[2] Univ Munich, Munich, Germany
[3] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany
来源：
Oncology Research and Treatment | 2015年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P226
引用
收藏
页码：66 / 67
页数：2
相关论文
共 50 条
  • [21] Comparison of 2 Doses of Intravenous (IV) Temsirolimus (Temsr) in Patients with Relapsed/Refractory Mantle Cell Lymphoma (MCL)
    Jurczak, Wojciech
    Ramanathan, Sundra
    Giri, Pratyush
    Di Raimondo, Francesco
    Mocikova, Heidi
    Clancy, Jill
    Lechuga, Mariajose
    Casey, Michelle
    Boni, Joseph P.
    Giza, Agnieszka
    Hess, Georg
    BLOOD, 2016, 128 (22)
  • [22] Efficacy and Safety Of Treatments For Relapsed Or Refractory Mantle Cell Lymphoma (MCL): Results Of a Systematic Literature Review
    Njue, Annete
    Trask, Peter C.
    Colosia, Ann
    Olivares, Robert
    Khan, Shahnaz
    Abbe, Adeline
    Police, Rachel Lee
    Wang, Jianmin
    Sherrill, Elizabeth
    Kaye, James A.
    Awan, Farrukh T.
    BLOOD, 2013, 122 (21)
  • [23] Temsirolimus in Relapsed and/or Refractory Mantle Cell Lymphoma Profile Report
    Hoy, Sheridan M.
    McKeage, Kate
    BIODRUGS, 2011, 25 (03) : 193 - 195
  • [24] Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma
    Maruyama, Dai
    Nagai, Hirokazu
    Fukuhara, Noriko
    Kitano, Toshiyuki
    Ishikawa, Takayuki
    Shibayama, Hirohiko
    Choi, Ilseung
    Hatake, Kiyohiko
    Uchida, Toshiki
    Nishikori, Momoko
    Kinoshita, Tomohiro
    Matsuno, Yoshihiro
    Nishikawa, Tomoaki
    Takahara, Satoko
    Tobinai, Kensei
    CANCER SCIENCE, 2016, 107 (12) : 1785 - 1790
  • [25] Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?
    Kirschey, Sebastian
    Wagner, Susanne
    Hess, Georg
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [26] Clinical Efficacy and Safety in Relapsed/Refractory Mantle Cell Lymphoma: A Systematic Literature Review
    Njue, Annete
    Colosia, Ann
    Trask, Peter C.
    Olivares, Robert
    Khan, Shahnaz
    Abbe, Adeline
    Police, Rachel
    Wang, Jianmin
    Ruiz-Soto, Rodrigo
    Kaye, James A.
    Awan, Farrukh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (01): : 1 - 12
  • [27] Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma
    G Hess
    U Keller
    C W Scholz
    M Witzens-Harig
    J Atta
    C Buske
    S Kirschey
    C Ruckes
    C Medler
    C van Oordt
    W Klapper
    M Theobald
    M Dreyling
    Leukemia, 2015, 29 : 1695 - 1701
  • [28] Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma
    Hess, G.
    Keller, U.
    Scholz, C. W.
    Witzens-Harig, M.
    Atta, J.
    Buske, C.
    Kirschey, S.
    Ruckes, C.
    Medler, C.
    van Oordt, C.
    Klapper, W.
    Theobald, M.
    Dreyling, M.
    LEUKEMIA, 2015, 29 (08) : 1695 - 1701
  • [29] IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/Refractory Mantle-Cell Lymphoma (MCL) Treated with Ibrutinib in Routine Clinical Practice
    Manuel Sancho, Juan
    Marin, Ana
    Fernandez, Silvia
    Javier Capote, Francisco
    Canigral, Carolina
    Grande, Carlos
    Donato, Eva
    Zeberio, Izaskun
    Manuel Puerta, Jose
    Rivas, Alfredo
    Perez Ceballos, Elena
    Vale, Ana
    Martin, Alejandro
    Salar, Antonio
    Gonzalez Barca, Eva
    Teruel, Anabel
    Pastoriza, Carmen
    Conde Royo, Diego
    Sanchez, Joaquin
    Barrenetxea, Cristina
    Arranz, Reyes
    Hernandez Rivas, Jose Angel
    Ramirez, Josefa
    Jimenez, Aroa
    Loriente, Cristina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S258 - S259
  • [30] EVALUATION OF SAFETY, TOLERABILITY AND ACTIVITY: A REGISTRY FOR TEMSIROLIMUS-TREATED PATIENTS WITH MANTLE-CELL LYMPHOMA (MCL) IN THE USUAL HEALTH CARE SETTING
    Pelz, H.
    Hess, G.
    Dreyling, M.
    Kosch, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 632 - 632
12345